CareRx Renews Share Repurchase Program
News related to:CareRx Corporation · 2 min read
CareRx Corporation, Canada's leading provider of pharmacy services to seniors living and other congregate care communities, has received regulatory approval to renew its normal course issuer bid for share repurchases. The Toronto Stock Exchange has accepted the company’s notice to repurchase up to 1,750,000 of its common shares, representing approximately 2.75% of the 63,429,589 common shares issued and outstanding as of September 3, 2026.
According to Puneet Khanna, President and CEO of CareRx, the renewal of the share repurchase program underscores the company’s commitment to delivering robust cash generation and a disciplined capital allocation strategy.
The company plans to begin the share repurchase program on September 17, 2026, and it is expected to conclude on September 16, 2027, or earlier if the company completes its repurchase goals. The Toronto Stock Exchange has approved the company to purchase up to 7,105 common shares on any trading day, representing 25% of the average daily trading volume (ADTV) of 28,420 common shares for the six months ending August 31, 2026.
CareRx will use the Toronto Stock Exchange’s facilities, other designated exchanges, and alternative Canadian trading systems to purchase shares at prevailing market rates. The company may also make purchases through private agreements or share repurchase programs under issuer bid exemption orders issued by securities regulatory authorities. Any purchases made under such exemption orders will generally be at a discount to the prevailing market price.
The company has established an automatic repurchase plan with its designated broker to facilitate purchases during times when the company would typically be inactive in the market due to internal trading blackout periods or insider trading rules. Purchases made pursuant to the automatic repurchase plan will be based on the parameters prescribed by the Toronto Stock Exchange, applicable Canadian securities laws, and the terms of the written agreement with the company.
CareRx Corporation, founded as a national organization with a large network of pharmacy fulfillment centers, provides pharmacy services to seniors living in congregate care communities. The company leverages best-in-class technology to automate the preparation and verification of multi-dose compliance packaging of medications, ensuring the highest levels of safety and adherence for individuals with complex medication regimens. CareRx also actively works with its home operator partners to promote resident health, staff education, and medication system quality and efficiency.
The company's capital allocation strategy includes investing in organic and inorganic initiatives, such as capital expenditures for capacity expansion and margin improvement. CareRx will also consider selective acquisition opportunities that, in the opinion of management and the Board of Directors, will provide an attractive return on capital.
The press release concludes by noting that while the company intends to repurchase common shares under its normal course issuer bid, there can be no assurance that any such purchases will be completed. All common shares repurchased under the bid will be cancelled.